Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.942.772.742.942.97

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.94 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.94
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.94
6.14
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,661.1 Cr 1.7% -4.9% 34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.7%

-4.9%

34.8%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses